Nutraceuticals in dyslipidemia

An alternative approach

Saurabh Agarwal, Sereen R. Thomson, G. Shivaprakash

Research output: Contribution to journalReview article

Abstract

Dyslipidemia is a well-known modifiable risk factor for preventing cardiovascular diseases. The present therapy mainly aiming at pharmacological treatment to reduce lipid levels may not be effective in each individual to meet the target levels. Diet and lifestyle modification has an important role in treating such chronic illnesses. Nutraceuticals, which are derived from food products, provide one such alternate therapy for the management of dyslipidemia. Some of them have proven to be effective for treating dyslipidemia while others require further studies. Much work is still required to understand the pharmacokinetics and mechanism of action of these products. Nutraceuticals hold promise in the clinical management of dyslipidemia and can be used as primary preventive therapy as more evidence from studies comes in light.

Original languageEnglish
Pages (from-to)38-42
Number of pages5
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume10
Issue number1
DOIs
Publication statusPublished - 01-01-2017

Fingerprint

Dyslipidemias
Dietary Supplements
Diet Therapy
Therapeutics
Life Style
Chronic Disease
Cardiovascular Diseases
Pharmacokinetics
Pharmacology
Lipids
Light
Food

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

@article{ce02364c5c564a89bfdfbc3b74330c53,
title = "Nutraceuticals in dyslipidemia: An alternative approach",
abstract = "Dyslipidemia is a well-known modifiable risk factor for preventing cardiovascular diseases. The present therapy mainly aiming at pharmacological treatment to reduce lipid levels may not be effective in each individual to meet the target levels. Diet and lifestyle modification has an important role in treating such chronic illnesses. Nutraceuticals, which are derived from food products, provide one such alternate therapy for the management of dyslipidemia. Some of them have proven to be effective for treating dyslipidemia while others require further studies. Much work is still required to understand the pharmacokinetics and mechanism of action of these products. Nutraceuticals hold promise in the clinical management of dyslipidemia and can be used as primary preventive therapy as more evidence from studies comes in light.",
author = "Saurabh Agarwal and Thomson, {Sereen R.} and G. Shivaprakash",
year = "2017",
month = "1",
day = "1",
doi = "10.22159/ajpcr.2017.v10i1.15360",
language = "English",
volume = "10",
pages = "38--42",
journal = "Asian Journal of Pharmaceutical and Clinical Research",
issn = "0974-2441",
publisher = "Innovare Academics Sciences Pvt. Ltd",
number = "1",

}

Nutraceuticals in dyslipidemia : An alternative approach. / Agarwal, Saurabh; Thomson, Sereen R.; Shivaprakash, G.

In: Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, No. 1, 01.01.2017, p. 38-42.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Nutraceuticals in dyslipidemia

T2 - An alternative approach

AU - Agarwal, Saurabh

AU - Thomson, Sereen R.

AU - Shivaprakash, G.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Dyslipidemia is a well-known modifiable risk factor for preventing cardiovascular diseases. The present therapy mainly aiming at pharmacological treatment to reduce lipid levels may not be effective in each individual to meet the target levels. Diet and lifestyle modification has an important role in treating such chronic illnesses. Nutraceuticals, which are derived from food products, provide one such alternate therapy for the management of dyslipidemia. Some of them have proven to be effective for treating dyslipidemia while others require further studies. Much work is still required to understand the pharmacokinetics and mechanism of action of these products. Nutraceuticals hold promise in the clinical management of dyslipidemia and can be used as primary preventive therapy as more evidence from studies comes in light.

AB - Dyslipidemia is a well-known modifiable risk factor for preventing cardiovascular diseases. The present therapy mainly aiming at pharmacological treatment to reduce lipid levels may not be effective in each individual to meet the target levels. Diet and lifestyle modification has an important role in treating such chronic illnesses. Nutraceuticals, which are derived from food products, provide one such alternate therapy for the management of dyslipidemia. Some of them have proven to be effective for treating dyslipidemia while others require further studies. Much work is still required to understand the pharmacokinetics and mechanism of action of these products. Nutraceuticals hold promise in the clinical management of dyslipidemia and can be used as primary preventive therapy as more evidence from studies comes in light.

UR - http://www.scopus.com/inward/record.url?scp=85010434978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010434978&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2017.v10i1.15360

DO - 10.22159/ajpcr.2017.v10i1.15360

M3 - Review article

VL - 10

SP - 38

EP - 42

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 1

ER -